Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $28.16 and traded as high as $32.20. Acadia Healthcare shares last traded at $31.88, with a volume of 1,263,788 shares trading hands.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on ACHC. Guggenheim upped their price target on Acadia Healthcare from $38.00 to $39.00 and gave the stock a "buy" rating in a report on Thursday, July 30th. Barclays lifted their price target on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a report on Thursday, July 30th. KeyCorp upped their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a report on Tuesday, July 14th. Raymond James Financial downgraded Acadia Healthcare from a "strong-buy" rating to an "outperform" rating and set a $39.00 target price on the stock. in a research report on Monday, September 28th. Finally, UBS Group raised their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research report on Thursday, July 9th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of "Hold" and a consensus target price of $30.69.
Check Out Our Latest Report on ACHC
Acadia Healthcare Stock Performance
The company's fifty day moving average is $28.86 and its 200 day moving average is $28.16. The company has a market cap of $2.97 billion, a P/E ratio of -2.56, a price-to-earnings-growth ratio of 10.12 and a beta of 0.63. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analysts' expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. Acadia Healthcare's quarterly revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, equities analysts predict that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. Allworth Financial LP bought a new position in Acadia Healthcare in the second quarter worth about $45,000. Global Retirement Partners LLC bought a new stake in Acadia Healthcare in the second quarter worth $68,000. Integrated Wealth Concepts LLC bought a new position in Acadia Healthcare in the 2nd quarter worth about $79,000. Quantbot Technologies LP purchased a new stake in shares of Acadia Healthcare during the second quarter valued at approximately $88,000. Finally, WINTON GROUP Ltd boosted its stake in Acadia Healthcare by 1.4% during the 2nd quarter. WINTON GROUP Ltd now owns 255,451 shares of the company's stock valued at $7,543,000 after purchasing an additional 3,449 shares during the last quarter.
About Acadia Healthcare
(
Get Free Report)
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.
Acadia's services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.
Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.